Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Antipsychotics and Neuroleptics Toxicity clinical trials
A small indexed set (2 trials) with no open enrollment listed right now.
Corpus placement: #7,188 of 28,707 conditions by registered trial count.
2 US clinical trials · none currently recruiting · #7,188 of 28,707 conditions by registered trial count
Antipsychotics and Neuroleptics Toxicity: 2 US clinical trials tracked, none currently recruiting.
Antipsychotics and Neuroleptics Toxicity is the subject of 2 registered US clinical trials on ClinicalTrials.gov, none currently recruiting. The most active sponsor is Brigham and Women's Hospital, running 1 of these trials.
Enrollment posture brief
Registry condition antipsychotics-and-neuroleptics-toxicity
OPEN 0 | RECR 0% | LATE 0 | EARLY 0 | RANK #7188 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Accelerated Phase Chronic Myelogenous Leukemia (0% recruiting · 12 trials)
Antipsychotics and Neuroleptics Toxicity has no open enrollment in this registry pull (2 archived studies). Peers show how other volume-matched labels compare on open share. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Antipsychotics and Neuroleptics Toxicity on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Antipsychotics and Neuroleptics Toxicity is recruiting below its size-band peers.
0 of 2 indexed trials (0%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Indexed trials (enrollment closed)
2 total, page 1 of 1
DIAMOND-Lewy Guidelines for Antipsychotic Use in Older Patients
Ohio State University
NCT06357195
Novel Application of Simulation for Providers to Overcome Decisional Gaps in High-risk Prescribing
Brigham and Women's Hospital
NCT04668248
Phase Distribution
Phase data not available
Top Sponsors
Named interventions
Most-linked intervention names on Antipsychotics and Neuroleptics Toxicity records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Antipsychotics and Neuroleptics Toxicity trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Antipsychotics and Neuroleptics Toxicity page
2 registered trials, 0 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- No Antipsychotics and Neuroleptics Toxicity trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Brigham and Women's Hospital sponsors the most Antipsychotics and Neuroleptics Toxicity trials on record, review their full trial history before evaluating a specific study. See Brigham and Women's Hospital's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Antipsychotics and Neuroleptics Toxicity condition card totals 2 registered trials; most-linked intervention Online educational training; top US site state Ohio. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.